Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 7Gastrointestinal 7Genitourinary 4CNS 3Breast 3Gynecologic 2Other 1Head & Neck 1Endocrine 1Dermatologic 1

Conditions

Mouth Neoplasms 1

Interventions

Cisplatin 5lenvatinib 4Fentanyl 4Morphine 3Fluorouracil 3Docetaxel 3trametinib 2selpercatinib 2pralsetinib 2pembrolizumab 2nimotuzumab 2larotrectinib 2dabrafenib 2cabozantinib 2anlotinib 2Thyrotropin Alfa 2Saline Solution 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Norepinephrine 2Metformin 2Indocyanine Green 2Gabapentin 2Cinacalcet 2Cetuximab 2Carboplatin 2Benzydamine 2Acetaminophen 2xiaojin wan 1vandetanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Propofol × Head & Neck × Clear all
NCT05606315 2024-01-09

RemImazolam Besylate for ICU-sedation in Patients With Mechanical Ventilation After Oral and Maxillofacial Surgery

Nanfang Hospital, Southern Medical University

Phase 4 Unknown
285 enrolled
Head & Neck

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡